AI assistant
aTYR PHARMA INC — Director's Dealing 2019
Feb 8, 2019
34337_dirs_2019-02-08_5d71744e-fd29-4cc7-ac51-218fa516e52e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2019-02-06
Reporting Person: Krueger Nancy (General Counsel)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14999 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $17.74 | 2024-10-10 | Common Stock (35608) | Direct | |
| Stock Option (right to buy) | $9.15 | 2025-04-17 | Common Stock (6286) | Direct | |
| Stock Option (right to buy) | $14.00 | 2025-05-06 | Common Stock (8800) | Direct | |
| Stock Option (right to buy) | $10.24 | 2025-10-01 | Common Stock (17000) | Direct | |
| Stock Option (right to buy) | $6.14 | 2026-01-27 | Common Stock (20000) | Direct | |
| Stock Option (right to buy) | $3.06 | 2026-09-13 | Common Stock (36500) | Direct | |
| Stock Option (right to buy) | $3.30 | 2027-02-07 | Common Stock (35000) | Direct | |
| Stock Option (right to buy) | $3.30 | 2028-02-06 | Common Stock (50000) | Direct | |
| Stock Option (right to buy) | $0.85 | 2028-05-16 | Common Stock (50000) | Direct | |
| Restricted Stock Units | $ | Common Stock (25000) | Direct |
Footnotes
F1: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning November 7, 2014. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F2: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning May 17, 2015. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F3: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning June 6, 2015. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F4: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning November 1, 2015. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F5: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning February 1, 2016. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F6: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning October 13, 2016. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F7: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning March 7, 2017. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F8: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning March 6, 2018. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F9: The shares subject to this option shares vest and become exercisable in 48 monthly installments beginning June 16, 2018. This option is subject to accelerated vesting upon termination without cause upon a change in control of the Issuer.
F10: The restricted stock units (RSUs) are scheduled to vest in two equal annual installments beginning May 16, 2019, such that this grant will be fully vest on May 16, 2020. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
F11: Each RSU represents a contingent right to receive one share of the Issuer's common stock.